RP 1 Pill — YELLOW;WHITE CAPSULE, 14mm — Ramipril

RP pill photo
View full Ramipril profile
ImprintRP / 1
ColourYELLOW;WHITE
ShapeCAPSULE
Size14
StrengthRAMIPRIL 1.25 mg
Dosage formCapsule
ManufacturerActavis Pharma, Inc.
NDC16252-570
Schedule—
Availability—
IngredientsRAMIPRIL[RAMIPRILAT]

What does this imprint mean?

The imprint "RP 1" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Ramipril

Uses and warnings

BOXED WARNING: "WARNING: FETAL TOXICITY" - "Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus"; discontinue ramipril as soon as pregnancy is detected. Other major warnings/contraindications include angioedema (more frequent in Black patients and with concomitant mTOR inhibitors), contraindication in patients with a history of ACE-inhibitor-associated angioedema, with neprilysin inhibitors (within 36 hours of switching), and with aliskiren in diabetics; also hypotension in volume-depleted patients, renal impairment requiring monitoring, and hyperkalemia risk.

Ramipril capsules are indicated for: - Hypertension, to lower blood pressure and reduce the risk of fatal and nonfatal cardiovascular events - Reduction of risk of myocardial infarction, stroke, and death from cardiovascular causes in patients at high risk - Heart failure post-myocardial infarction, in stable patients who show signs of congestive heart failure within a few days after an acute MI.

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Ramipril

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 995a6ce7-bdcb-4123-8c82-df2038c40c4b.xml